TEL AVIV, ISRAEL / ACCESSWIRE / June 5, 2018 / Elbit Imaging Ltd. (TASE: EMITF; NASDAQ: EMITF) ("Elbit" or the "Company") announced today, that on May 31, 2018 it completed the full redemption of its series H notes.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of business: (i) Medical Industries through our indirect holdings in InSightec Ltd. and Gamida Cell Ltd.; (ii) Plots in India which are designated for sale (and which were initially designated for residential projects); (iii) Plots in Eastern Europe which are designated for sale (and which were initially designated for development of commercial centers).
For Further Information:
CEO and Chairman of the Board of Directors
SOURCE: Elbit Imaging, Ltd.